Acquisition of Hinshelwood Building to provide additional space at The Oxford Science Park

The Oxford Science Park (TOSP), one of Europe’s leading locations for science and technology companies, has further expanded its capacity to accommodate innovative firms with the acquisition of the Hinshelwood Building. The 31,581 sq ft building is situated at the centre of the Park.

The transaction is part of The Oxford Science Park’s ongoing investment programme, providing the support infrastructure for growing companies as they address global health and environmental challenges. This programme also includes six new R&D buildings, occupying over 600,000 sq ft, to be constructed over the next three years. The first of these is The Iversen Building (86,000 sq ft), Oxford’s first speculative lab-ready building, which is expected to complete this summer.

The Hinshelwood Building is an important strategic site at the heart of The Oxford Science Park and has been earmarked for some time as one of our priority investments.  We are therefore delighted to have completed the acquisition. Taking control of the building enhances our ability to provide a balance of flexible office and laboratory space to our fast-growing base of occupiers as well as new companies moving to the Park.

Rory Maw, CEO of The Oxford Science Park

 

Recent news

East West Rail publishes You Said, We Did – Autumn Update

East West Rail publishes You Said, We Did – Autumn Update

East West Railway Company (EWR Co.) held a reception in Parliament this week to coincide with the launch of its report You Said, We Did – Autumn Update. The reception was attended by Advanced Oxford’s MD, Sarah Haywood, and other members of the Oxford to Cambridge...

read more
New Moderna Innovation and Technology Centre opens at Harwell

New Moderna Innovation and Technology Centre opens at Harwell

The government has announced a major boost for the UK’s life sciences sector as the new Moderna Innovation and Technology Centre officially opens in Oxfordshire. The facility sits on the Harwell Campus and marks a significant step forward for vaccine development,...

read more
Loading...